Synthesis and biological activity of semipeptoid farnesyltransferase inhibitors

Hadas Reuveni, Alex Gitler, Enrique Poradosu, Chaim Gilon, Alexander Levitzki*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Semipeptoids derived from the Ras farnesyl transferase inhibitor, CVFM, were synthesized by the Simultaneous Multiple Analogue Peptide Synthesis methodology. The semipeptoids were screened for their in vitro inhibition potency towards farnesyl transferase and geranylgeranyl transferase. Structure-activity relationship studies led to a potent and selective inhibitor, HR-11, which blocks Ras farnesylation in vitro with an IC50 of 1.2 nM. The cell permeable methyl ester derivative of HR-11, HR-12, inhibits Ras farnesylation in intact cells with an IC50 of 10 μM and with no detectable inhibition of Rap1A/K-rev geranyl-geranylation.

Original languageEnglish
Pages (from-to)85-92
Number of pages8
JournalBioorganic and Medicinal Chemistry
Volume5
Issue number1
DOIs
StatePublished - Jan 1997

Fingerprint

Dive into the research topics of 'Synthesis and biological activity of semipeptoid farnesyltransferase inhibitors'. Together they form a unique fingerprint.

Cite this